<DOC>
	<DOC>NCT00938015</DOC>
	<brief_summary>The aim of this study is to evaluate if the data obtained in controlled clinical trials are confirmed when Enbrel is used in usual clinical practice in Belgium according to local reimbursement criteria.</brief_summary>
	<brief_title>Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Psoriatic</mesh_term>
	<criteria>Active erosive psoriatic arthritis of polyarticular type or active erosive or with joint space narrowing psoriatic arthritis of oligoarticular type At least 18 years old Have fulfilled reimbursement criteria for Enbrel in psoriatic arthritis of polyarticular type or oligoarticular type Physician decides to prescribe Enbrel or patient is already on Enbrel Give written informed consent at time of inclusion to study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>postmarketing surveillance</keyword>
	<keyword>Enbrel</keyword>
	<keyword>psoriatic arthritis</keyword>
</DOC>